why choose us

First received: September 16, 2022

Clinical Trial: Empagliflozin in ESKD - A Feasibility Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Kidney Failure, Chronic

Study Type: INTERVENTIONAL


Official Title: Empagliflozin in ESKD - A Feasibility Study

Brief Summary: The aim of this study is to learn about the safety of empagliflozin in dialysis patients as a preparation for a future large clinical trial.Empagliflozin has been approved by the Food and Drug Administration for the treatment of either type 2 diabetes, heart failure, or chronic kidney disease among patients not on dialysis.The use of empagliflozin has not been studied or approved among patients on dialysis for kidney failure because empagliflozin acts on the kidneys.However, recent experimental studies have…

Read more